BC Platforms

BC Platforms is a global leader in building data networks for the life sciences industry, offering a versatile technology platform for personalized medicine to accelerate the translation of innovations into clinical practice. With its innovative technology, the company is creating a patient-centered infinite loop between the life sciences and healthcare sectors. The data generated, harmonized, and managed by BC Platforms from diverse biobanks and healthcare institutions is available to pharmaceutical and biotech companies to enhance their core competencies in R&D. At the same time, BC Platforms enables the stratification of patients into targeted therapies, fulfilling the promise of more personalized healthcare. BC Platforms' high-performance genomic data discovery and analysis platform facilitates flexible data integration, secure analysis, and the interpretation of molecular and clinical information. BC Platforms has developed BCRQUEST.com, a global network of data partners that provides access to high-quality real-world data. This rapidly growing network spans numerous sites, including large hospital networks covering 20 countries across five continents, providing standard care data for over 23 million patients. BC Platforms’ platform seamlessly facilitates access to highly enriched data for drug development. Founded in 1997 as a spin-off from the MIT Whitehead project, the company has over 25 years of close collaboration with a network of leading researchers, developers, and industry partners, backed by a strong scientific tradition. Headquartered in Zurich, Switzerland, BC Platforms has R&D departments in Espoo, Finland, and Singapore, with offices in London and Boston.